Dana Investment Advisors Inc. Buys 25,861 Shares of Cigna Group $CI

Posted by Brian Himes on May 17th, 2026

Dana Investment Advisors Inc. boosted its stake in Cigna Group (NYSE:CI – Free Report) by 358.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,067 shares of the health services provider’s stock after purchasing an additional 25,861 shares during the period. Dana Investment Advisors Inc.’s holdings in Cigna Group were worth $9,101,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. OLD National Bancorp IN boosted its holdings in Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after purchasing an additional 37 shares during the last quarter. Leavell Investment Management Inc. boosted its holdings in Cigna Group by 3.8% in the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock valued at $318,000 after purchasing an additional 40 shares during the last quarter. Physician Wealth Advisors Inc. boosted its holdings in Cigna Group by 1.5% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock valued at $782,000 after purchasing an additional 41 shares during the last quarter. Cookson Peirce & Co. Inc. boosted its holdings in Cigna Group by 0.8% in the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock valued at $1,428,000 after purchasing an additional 41 shares during the last quarter. Finally, Signet Financial Management LLC boosted its holdings in Cigna Group by 0.6% in the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock valued at $2,150,000 after purchasing an additional 41 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 205,904 shares of company stock valued at $60,277,068. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Leerink Partners boosted their target price on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Mizuho set a $330.00 target price on shares of Cigna Group in a report on Friday, May 1st. Barclays boosted their target price on shares of Cigna Group from $303.00 to $310.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a report on Friday, May 1st. Finally, Robert W. Baird set a $337.00 target price on shares of Cigna Group in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $338.35.

View Our Latest Report on CI

Cigna Group Price Performance

Cigna Group stock opened at $285.25 on Friday. The company’s 50 day simple moving average is $274.95 and its 200-day simple moving average is $275.97. The company has a market capitalization of $75.46 billion, a price-to-earnings ratio of 12.09, a price-to-earnings-growth ratio of 1.00 and a beta of 0.30. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is 26.45%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.